6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Published on November 19, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of November 2026
Commission File Number: 001-38607
ENDAVA PLC
(Name of Registrant)
125 Old Broad Street
London EC2N 1AR
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: ☒ Form 20-F ☐ Form 40-F
NYSE Notice of Noncompliance
On November 18, 2026, Endava plc (the “Company”) received a notice of noncompliance from the New York Stock Exchange (the “NYSE”) noting that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual, Annual and Quarterly Report Timely Filing Criteria, due to the delayed filing of the Company’s Annual Report on Form 20-F for the fiscal year ended June 30, 2026 (the “Annual Report”).
The NYSE has informed the Company that it has up to six months from the filing due date of November 17, 2026 to file the Annual Report to regain compliance (the “Initial Cure Period”). If the Company does not regain compliance within the Initial Cure Period, the NYSE may, in its sole discretion, grant an additional period of up to six months, or may determine to commence suspension and delisting procedures. The Company intends to file the Annual Report and regain compliance within the Initial Cure Period; however, there can be no assurance that the Company will ultimately regain compliance with all applicable NYSE listing standards.
On November 19, 2026, the Company issued a press release announcing its receipt of the NYSE notice. A copy of the press release is furnished as Exhibit 99.1 to this Form 6-K and is incorporated herein by reference.
INCORPORATION BY REFERENCE
Exhibit 99.1 is hereby expressly incorporated by reference into the Company’s registration statement on Form F-3 (File No. 333-229213) and registration statements on Form S-8 (File Nos. 333-228717, 333-248904, 333-259900, 333-268067, 333-274571, 333-282207 and 333-290043), and any related prospectuses, as such registration statements may be amended from time to time, and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
EXHIBIT LIST
| Exhibit |
Description | |
| 99.1 | Press Release, dated November 19, 2026 | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ENDAVA PLC | ||||||
| Date: November 19, 2026 | By: | /s/ Conor McShane | ||||
| Name: Conor McShane | ||||||
| Title: Interim Chief Financial Officer | ||||||